chr7-152648639-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000495707.1(XRCC2):n.868T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000278 in 1,437,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000495707.1 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group UInheritance: AR Classification: MODERATE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- premature ovarian failure 17Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- spermatogenic failure 50Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XRCC2 | NM_005431.2 | c.*3T>C | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000359321.2 | NP_005422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XRCC2 | ENST00000495707.1 | n.868T>C | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
XRCC2 | ENST00000359321.2 | c.*3T>C | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_005431.2 | ENSP00000352271.1 | |||
XRCC2 | ENST00000698506.1 | c.*3T>C | 3_prime_UTR_variant | Exon 2 of 2 | ENSP00000513758.1 | |||||
ENSG00000298894 | ENST00000758786.1 | n.254-12071A>G | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000873 AC: 2AN: 229068 AF XY: 0.00000808 show subpopulations
GnomAD4 exome AF: 0.00000278 AC: 4AN: 1437268Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 713618 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
The XRCC2 c.*3T>C variant has not been reported in individuals with XRCC2-related conditions in the published literature. The frequency of this variant in the general population, 0.0000087 (2/229068 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect XRCC2 mRNA splicing. Based on the available information, we are unable to determine the clinical significance of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at